Compare CDMOs with infectious disease manufacturing expertise for antibiotics, antivirals, vaccines, and pandemic-readiness programs. Filter by biosafety level, modality, and capacity.
222 companies listed
Infectious disease manufacturing covers antibiotics (small molecule, complex natural products), antivirals (small molecule and biologic), vaccines (live-attenuated, inactivated, subunit, mRNA), and emerging modalities like monoclonal antibodies for prophylaxis. Post-pandemic, governments and organizations are investing heavily in manufacturing surge capacity and platform technologies.
Biosafety containment is essential for vaccine production. Live-attenuated vaccines require BSL-2 manufacturing. Viral challenge studies and certain vector production require BSL-3. CDMOs must demonstrate validated biosafety engineering controls, decontamination procedures, and personnel training. Ask about their biosafety committee oversight and facility classification.
Speed-to-scale capability differentiates infectious disease CDMOs. Pandemic preparedness programs prioritize CDMOs that can scale from clinical to commercial manufacturing within months, not years. Platform technologies (mRNA manufacturing lines, modular single-use bioreactors) enable rapid campaign switching between products. The ability to handle multiple products in segregated suites is a key differentiator.
Austria
Polymun Scientific Immunbiologische Forschung GmbH is an Austrian specialist CDMO in biopharmaceuticals and liposomal/lipid nanoparticle (LNP) formulations. Offers contract development and manufacturing from gene to clinical grade material for innovator and biosimilar products. Unique expertise in liposomal drug formulations that protect, transport, and release drugs at target sites. Also maintains R&D projects including liposomal superoxide dismutase, recombinant porcine trypsin, and HIV antibodies/antigens. FDA registered for analysis, API manufacture, and manufacture.
India
Prachi Pharmaceuticals Pvt Ltd, established in 1988, is an Indian GMP-certified manufacturer, supplier, importer, and exporter of Active Pharmaceutical Ingredients, iodine compounds, and specialty chemicals. Based in Mumbai, they have 26-50 employees with annual turnover of INR 25-100 Cr. Their product range includes iodine compounds, triphenyl methane, potassium metaperiodate, chlorhexidine digluconate, camphor quinone, closantel base, L-seleno methionine, and veterinary products. They are listed on PharmaSource and PharmaCompass as an API manufacturer with USDMF filings including furosemide.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.